[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Immune Checkpoint Blockers Market Report 2017

October 2017 | 95 pages | ID: U5D55495638PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Immune Checkpoint Blockers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Immune Checkpoint Blockers in these regions, from 2012 to 2022 (forecast).
United States Immune Checkpoint Blockers market competition by top manufacturers/players, with Immune Checkpoint Blockers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bristol Myers Squibb
  • Merck
  • AstraZeneca
  • Roche
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Anti-PD-L1 Drug
  • Anti-PD-1 Drug
  • CTLA4
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Immune Checkpoint Blockers for each application, including
  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer'
  • Prostate Cancer
  • Melanoma
  • Blood Cancers
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Immune Checkpoint Blockers Market Report 2017

1 IMMUNE CHECKPOINT BLOCKERS OVERVIEW

1.1 Product Overview and Scope of Immune Checkpoint Blockers
1.2 Classification of Immune Checkpoint Blockers by Product Category
  1.2.1 United States Immune Checkpoint Blockers Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Immune Checkpoint Blockers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-PD-L1 Drug
  1.2.4 Anti-PD-1 Drug
  1.2.5 CTLA4
1.3 United States Immune Checkpoint Blockers Market by Application/End Users
  1.3.1 United States Immune Checkpoint Blockers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Lung Cancer
  1.3.3 Colorectal Cancer
  1.3.4 Breast Cancer?
  1.3.5 Prostate Cancer
  1.3.6 Melanoma
  1.3.7 Blood Cancers
1.4 United States Immune Checkpoint Blockers Market by Region
  1.4.1 United States Immune Checkpoint Blockers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Immune Checkpoint Blockers Status and Prospect (2012-2022)
  1.4.3 Southwest Immune Checkpoint Blockers Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Immune Checkpoint Blockers Status and Prospect (2012-2022)
  1.4.5 New England Immune Checkpoint Blockers Status and Prospect (2012-2022)
  1.4.6 The South Immune Checkpoint Blockers Status and Prospect (2012-2022)
  1.4.7 The Midwest Immune Checkpoint Blockers Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Immune Checkpoint Blockers (2012-2022)
  1.5.1 United States Immune Checkpoint Blockers Sales and Growth Rate (2012-2022)
  1.5.2 United States Immune Checkpoint Blockers Revenue and Growth Rate (2012-2022)

2 UNITED STATES IMMUNE CHECKPOINT BLOCKERS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immune Checkpoint Blockers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Immune Checkpoint Blockers Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Immune Checkpoint Blockers Average Price by Players/Suppliers (2012-2017)
2.4 United States Immune Checkpoint Blockers Market Competitive Situation and Trends
  2.4.1 United States Immune Checkpoint Blockers Market Concentration Rate
  2.4.2 United States Immune Checkpoint Blockers Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immune Checkpoint Blockers Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNE CHECKPOINT BLOCKERS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Immune Checkpoint Blockers Sales and Market Share by Region (2012-2017)
3.2 United States Immune Checkpoint Blockers Revenue and Market Share by Region (2012-2017)
3.3 United States Immune Checkpoint Blockers Price by Region (2012-2017)

4 UNITED STATES IMMUNE CHECKPOINT BLOCKERS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Immune Checkpoint Blockers Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Immune Checkpoint Blockers Revenue and Market Share by Type (2012-2017)
4.3 United States Immune Checkpoint Blockers Price by Type (2012-2017)
4.4 United States Immune Checkpoint Blockers Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IMMUNE CHECKPOINT BLOCKERS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Immune Checkpoint Blockers Sales and Market Share by Application (2012-2017)
5.2 United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNE CHECKPOINT BLOCKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immune Checkpoint Blockers Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Immune Checkpoint Blockers Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca
  6.3.2 Immune Checkpoint Blockers Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Immune Checkpoint Blockers Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 IMMUNE CHECKPOINT BLOCKERS MANUFACTURING COST ANALYSIS

7.1 Immune Checkpoint Blockers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immune Checkpoint Blockers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immune Checkpoint Blockers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immune Checkpoint Blockers Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNE CHECKPOINT BLOCKERS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Immune Checkpoint Blockers Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Immune Checkpoint Blockers Sales Volume Forecast by Type (2017-2022)
11.3 United States Immune Checkpoint Blockers Sales Volume Forecast by Application (2017-2022)
11.4 United States Immune Checkpoint Blockers Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Immune Checkpoint Blockers
Figure United States Immune Checkpoint Blockers Market Size (K Units) by Type (2012-2022)
Figure United States Immune Checkpoint Blockers Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-PD-L1 Drug Product Picture
Figure Anti-PD-1 Drug Product Picture
Figure CTLA4 Product Picture
Figure United States Immune Checkpoint Blockers Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Immune Checkpoint Blockers by Application in 2016
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Breast Cancer? Examples
Table Key Downstream Customer in Breast Cancer?
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Blood Cancers Examples
Table Key Downstream Customer in Blood Cancers
Figure United States Immune Checkpoint Blockers Market Size (Million USD) by Region (2012-2022)
Figure The West Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immune Checkpoint Blockers Sales (K Units) and Growth Rate (2012-2022)
Figure United States Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immune Checkpoint Blockers Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Immune Checkpoint Blockers Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Immune Checkpoint Blockers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immune Checkpoint Blockers Sales Share by Players/Suppliers
Figure 2017 United States Immune Checkpoint Blockers Sales Share by Players/Suppliers
Figure United States Immune Checkpoint Blockers Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Immune Checkpoint Blockers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers
Figure 2017 United States Immune Checkpoint Blockers Revenue Share by Players/Suppliers
Table United States Market Immune Checkpoint Blockers Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Immune Checkpoint Blockers Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Immune Checkpoint Blockers Market Share of Top 3 Players/Suppliers
Figure United States Immune Checkpoint Blockers Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immune Checkpoint Blockers Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immune Checkpoint Blockers Product Category
Table United States Immune Checkpoint Blockers Sales (K Units) by Region (2012-2017)
Table United States Immune Checkpoint Blockers Sales Share by Region (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Share by Region (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Market Share by Region in 2016
Table United States Immune Checkpoint Blockers Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Immune Checkpoint Blockers Revenue Share by Region (2012-2017)
Figure United States Immune Checkpoint Blockers Revenue Market Share by Region (2012-2017)
Figure United States Immune Checkpoint Blockers Revenue Market Share by Region in 2016
Table United States Immune Checkpoint Blockers Price (USD/Unit) by Region (2012-2017)
Table United States Immune Checkpoint Blockers Sales (K Units) by Type (2012-2017)
Table United States Immune Checkpoint Blockers Sales Share by Type (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Share by Type (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Market Share by Type in 2016
Table United States Immune Checkpoint Blockers Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Immune Checkpoint Blockers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Immune Checkpoint Blockers by Type (2012-2017)
Figure Revenue Market Share of Immune Checkpoint Blockers by Type in 2016
Table United States Immune Checkpoint Blockers Price (USD/Unit) by Types (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Growth Rate by Type (2012-2017)
Table United States Immune Checkpoint Blockers Sales (K Units) by Application (2012-2017)
Table United States Immune Checkpoint Blockers Sales Market Share by Application (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Market Share by Application (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Market Share by Application in 2016
Table United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)
Figure United States Immune Checkpoint Blockers Sales Growth Rate by Application (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol Myers Squibb Immune Checkpoint Blockers Sales Growth Rate (2012-2017)
Figure Bristol Myers Squibb Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)
Figure Bristol Myers Squibb Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Immune Checkpoint Blockers Sales Growth Rate (2012-2017)
Figure Merck Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)
Figure Merck Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Immune Checkpoint Blockers Sales Growth Rate (2012-2017)
Figure AstraZeneca Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)
Figure AstraZeneca Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Immune Checkpoint Blockers Sales Growth Rate (2012-2017)
Figure Roche Immune Checkpoint Blockers Sales Market Share in United States (2012-2017)
Figure Roche Immune Checkpoint Blockers Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Checkpoint Blockers
Figure Manufacturing Process Analysis of Immune Checkpoint Blockers
Figure Immune Checkpoint Blockers Industrial Chain Analysis
Table Raw Materials Sources of Immune Checkpoint Blockers Major Players/Suppliers in 2016
Table Major Buyers of Immune Checkpoint Blockers
Table Distributors/Traders List
Figure United States Immune Checkpoint Blockers Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Immune Checkpoint Blockers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Immune Checkpoint Blockers Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Type in 2022
Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Application in 2022
Table United States Immune Checkpoint Blockers Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immune Checkpoint Blockers Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories